Christopher E. Blunden
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 6
-
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Teena Chopra (3 shared papers)Dror Marchaim (3 shared papers)Jason M. Pogue (3 shared papers)Suchitha Bheemreddy (3 shared papers)Kayoko Hayakawa (3 shared papers)Paul Lephart (3 shared papers)Keith S. Kaye (3 shared papers)Maryann M. Shango (2 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (2 papers)American Journal of Infection Control (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)The Journal of Pediatrics (1 paper)American Journal of Medical Quality (1 paper)
- Partner nations
- United StatesIsraelPuerto Rico
In The Last Decade
Christopher E. Blunden
10 papers receiving 620 citations
Peers
Comparison fields: 5 of 72
- Molecular Medicine 430
- Applied Microbiology and Biotechnology 126
- Endocrinology 81
- Clinical Biochemistry 80
- Pharmacology 130
Countries citing papers authored by Christopher E. Blunden
This map shows the geographic impact of Christopher E. Blunden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Blunden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Blunden more than expected).
Fields of papers citing papers by Christopher E. Blunden
This network shows the impact of papers produced by Christopher E. Blunden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Blunden. The network helps show where Christopher E. Blunden may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher E. Blunden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 192 | |
| 2 | 2012 | 116 | |
| 3 | 2015 | 78 | |
| 4 | 2012 | 67 | |
| 5 | 2011 | 62 | |
| 6 | 2012 | 50 | |
| 7 | 2012 | 48 | |
| 8 | 2021 | 13 | |
| 9 | 2018 | 9 | |
| 10 | 2020 | 2 | |
| 11 | 2015 | 0 |
About Christopher E. Blunden
Christopher E. Blunden is a scholar working on Molecular Medicine, Pharmacology, Applied Microbiology and Biotechnology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 11 papers that have together received 637 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Coronary Artery Anomalies (1 paper), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (1 paper), Genomics and Phylogenetic Studies (1 paper), Chromosomal and Genetic Variations (1 paper), Cardiovascular Disease and Adiposity (1 paper) and Thyroid Disorders and Treatments (1 paper). The work is most often cited by research in Molecular Medicine (430 citations), Applied Microbiology and Biotechnology (126 citations), Endocrinology (81 citations), Clinical Biochemistry (80 citations) and Pharmacology (130 citations). Christopher E. Blunden has collaborated with scholars based in United States, Israel and Puerto Rico. Frequent co-authors include Teena Chopra, Dror Marchaim, Jason M. Pogue, Suchitha Bheemreddy, Kayoko Hayakawa, Paul Lephart, Keith S. Kaye, Maryann M. Shango, Sorabh Dhar and Robert A. Bonomo. Their work appears in journals such as Infection Control and Hospital Epidemiology, American Journal of Infection Control, Antimicrobial Agents and Chemotherapy, The Journal of Pediatrics and American Journal of Medical Quality.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.